Discovery and in vitro evaluation of potent kinase inhibitors:: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines

被引：31

作者：

Alberti, MJ ^{[1
]}

Auten, EP ^{[1
]}

Lackey, KE ^{[1
]}

McDonald, OB ^{[1
]}

Wood, ER ^{[1
]}

Preugschat, F ^{[1
]}

Cutler, GJ ^{[1
]}

Kane-Carson, L ^{[1
]}

Liu, W ^{[1
]}

Jung, DK ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 16期

关键词：

kinase inhibitor; VEGFR; GSK; Erb; EGFR;

D O I：

10.1016/j.bmcl.2005.05.100

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery, synthesis, potential binding mode, and in vitro kinase profile of several pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines as potent kinase inhibitors are discussed. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：3778 / 3781

页数：4

共 12 条

[1] Solution-phase synthesis of a library of 3,5,7-trisubstituted 3H-[1,2,3]triazolo[4,5-d]pyrimidines [J].

Baindur, N ;

Chadha, N ;

Player, MR .

JOURNAL OF COMBINATORIAL CHEMISTRY, 2003, 5 (05) :653-659

[2] Oncogenic kinase signalling [J].

Blume-Jensen, P ;

Hunter, T .

NATURE, 2001, 411 (6835) :355-365

[3] Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights [J].

Cherry, M ;

Williams, DH .

CURRENT MEDICINAL CHEMISTRY, 2004, 11 (06) :663-673

[4]

Cockerill S. G., 2002, CURR TOP MED CHEM, V2, P1001

[5] Protein kinases - the major drug targets of the twenty-first century? [J].

Cohen, P .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315

[6]

Graveleau N, 2003, SYNTHESIS-STUTTGART, P1739

[7] Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy [J].

Gschwind, A ;

Fischer, OM ;

Ullrich, A .

NATURE REVIEWS CANCER, 2004, 4 (05) :361-370

[8] Signaling networks: The origins of cellular multitasking [J].

Jordan, JD ;

Landau, EM ;

Iyengar, R .

CELL, 2000, 103 (02) :193-200

[9]

Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X

[10] Tyrosine kinase inhibitors.: 16.: 6,5,6-tricyclic benzothieno[3,2-d]pyrimidines and pyrimido[5,4-b]- and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase [J].

Showalter, HDH ;

Bridges, AJ ;

Zhou, HR ;

Sercel, AD ;

McMichael, A ;

Fry, DW .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) :5464-5474

← 1 2 →